Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-seropositive patients with Pneumocystis carinii pneumonia

European Journal of Clinical Investigation

Volumn 27, Issue 4, 1997, Pages 333-339

  Perenboom, R M ^a   Sauerwein, R W ^a   Beckers, P ^a   Van Schijndel, A C H W ^a   Van Steenwijk, R P ^b   Borleffs, J C C ^c   Van Leusen, R ^d   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Cytokine; HIV; Interleukin 1; Interleukin 1 receptor antagonist; Interleukin 6; Pneumocystis carinii pneumonia,; Soluble tumour necrosis factor receptor; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LAVAGE; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 0030891583     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1170661.x     Document Type: Article

References (38)

1. + cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990;172:937-45.
2. Shellito J, Suzara VV, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest 1990;85:1686-93.
3. Phair J, Munoz A, Detels R. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med 1990;332:161-5.
4. Von Behren LA, Pesanti EL. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis 1978;118:1051-9.
5. Masur H, Jones TC. The interaction in vitro of Pneumocystsis carinii with macrophages and L cells. J Exp Med 1978;147:157-70.
6. Forte M, Rahelu M, Stubberfield C et al. Interaction of human macrophages with Pneumocystis carinii. Int J Exp Pathol 1991;72:589-98.
7. Hidalgo HA, Helmke RJ, German VF, Mangos JA. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun 1992;60:1-7.
8. Pesanti EL. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J Infect Dis 1991;163:611-16.
9. Kolls JK, Beck JM, Nelson S, Summer WR, Shellito J. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumocystis. Am J Respir Cell Mol Biol. 1993;8:370-6.
10. Tamburrini E, De Luca A, Ventura G et al. Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-α by human macrophages. Med Microbiol Immunol. 1991;180:15-20.
11. Theus SA, Linke MJ, Andrews RP and Walzer PD. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Infect Immun 1993;61:4703-9.
12. Krishnan VL, Meager A, Mitchell DM and Pinching AJ. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin Exp Immunol 1990;80:156-60.
13. Kandil O, Fisman JA, Koziel H, Pinkston P, Rose RM, Remold HG. Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun 1994;62:644-50.
14. 125I-labelled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction (abstract). J Protozool 1991;38:28S-29S.
15. Donta ST, Pesanti EL. Tumor necrosis factor-α binds to specific receptors on Pneumocystis carinii (abstract). Clin Res 1990;38:352A.
16. Chen W, Havell EA, Gigliotti F and Harmsen AG. Interleukin-6 production in a murine model of Pneumocystis carinii Pneumonia: relation to resistance and inflammatory response. Infect Immun 1993;61:97-102.
17. Chen W, Havell EA, Moldawer LL et al. Interleukin-1: an important mediator of host resistance against Pneumocystis carinii. J.Exp. Med 1992;176:713-18.
18. Chen W, Havell EA, and Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992;60:1279-84.
19. Churukian CL, Schenk EA. Staining Pneumocystis carinii and fungi in unfixed specimens with ammoniacal silver using a microwave oven. J Histotechnol 1988;11:19-21.
20. Bozette SA, Sattler FR, Chiu J et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1451-7.
21. Perenboom RM, Schijndel van JCHW, Beckers P et al. Cytokine profiles in BAL and blood in HIV-seronegative patients with Pneumocystis carinii pneumonia. Eur J Clin Invest 1996;26:159-66.
22. Van Deuren M, Van der Ven-Jongekrijg J, Keuter M, Demacker PNM, Van der Meer JWM. Cytokine production in whole blood cultures. J Int Fed Clin Chem 1993;5:216-21.
23. Lisi PJ, Chu CW, Koch GA, Endres S, Lonneman G, Dinarello CA. Development and use of radio immunoassay for human interleukin-1ß. Lymphokine Res 1987;6:229-44.
24. Nerad JL, Griffith K, van der Meer JWM et al. Interleukin-1β (IL-1β), IL-1 receptor antagonist and TNF-α production in whole blood. J Leukoc Biol 1992;52:687-92.
25. Wijdenes J, Clement C, Klein B et al. Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. Mol Immunol 1991;28:1183-92.
26. Perenboom RM, Beckers P, van der Meer JWM et al. Pro-inflammatory cytokines in lung and blood during steroid induced Pneumocystis carinii pneumonia in rats. J Leukoc Biol 1996;6016:710-5.
27. Millar AB, Miller RF, Foley NM, Meager A, Semple SJ, Rook GA. Production of tumor necrosis factor-α by blood and lung mononuclear phagocytes from patients with human immmunodeficiency virus-related lung desease. Am J Respir Cell Mol Biol 1991;5(2):144-8.
28. McCrea KA, Ansor JA, Nall K et al. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994;150:696-703.
29. Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AMB, Lundgren JD. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995;151:1058-62.
30. Benfield TL, van Steenwijk R, Nielsen TL et al. Interleukin-8 and eisosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respir Med 1995;89:285-90.
31. Van Deuren M, van der Ven-Jongekrijg J, Demacker PNM et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994;169:157-61.
32. Godfried M, Poll van der T, Jansen J et al. Soluble receptors for tumour necrosis factor a putative marker for disease progression in HIV infection. AIDS 1993;7:33-6.
33. Zangerle R, Gallati H, Sarcletti M, Wachter H, Fuchs D. Tumour necrosis fator alpha and tumour necrosis factor receptors in individuals with human immunodeficiency virus infection. Immunology letters 1994;41:229-34.
34. Breen EC, Rezai AR, Kajima K et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-4.
35. Jones PD, Shelley L, Wakefield D. Tumour necrosis factor-α in advanced HIV infection in the absence of AIDS related secondary infections. J Acquir Immune Defic Syndr 1992;5:1266-71.
36. Huang ZB, Eden E. Effect of corticosteroids on IL-1β and TNF-α release by alveolar macrophages from patients with AIDS and PCP. Chest 1993;104:751-55.
37. Keuter M, Dharmana E, Hussein Gasem M et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994;169:1306-11.
38. Simpson SQ, Modi HN, Balk RA, Bone RC, Casey LC. Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med 1991;19:1060-6.